-
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
Thursday, October 31, 2024 - 2:52pm | 559Cannabis stocks are experiencing notable declines this Thursday, aligning with a general downturn across major economic indices. At the time of publication of this article, the S&P 500 index was trading down by 1.62%, the Nasdaq 100 by 2.44%, and the Dow Jones Industrial Average (DJIA) showed a...
-
Industry Proficiency: Big Cannabis Companies Are Getting Better At Costs, Here's How
Monday, August 12, 2024 - 7:35pm | 764Most financial results for cannabis companies in the second quarter of 2024 are here, and they are revealing some interesting trends. One of them is that U.S. multi-state operators (MSOs) are getting better at cutting costs and efficiency in the supply chain. It’s no surprise that MSOs have...
-
Tax Considerations For Investors In Financially Distressed Cannabis Companies
Tuesday, April 18, 2023 - 5:14pm | 9231Thanks to maturing markets, limited access to capital, and disproportionate tax burdens, many companies in the cannabis industry are facing major challenges in managing their debt. Creditors and investors are increasingly negotiating restructuring and refinancing agreements that allow distressed...
-
Fake Cannabis Tycoon Admits To $35M Fraudulent Scheme
Wednesday, January 18, 2023 - 8:34pm | 646It’s not just Congressional wannabes who invent lies about themselves to impress naïve voters and dupe their own party, it seems such posers have seeped into the cannabis industry as well. And, they're not just enhancing their resumé, they're stealing loads...
-
Does The SEC Have It Out For Cannabis Companies?
Thursday, October 27, 2022 - 4:32pm | 925The U.S. Securities and Exchange Commission (SEC) keeps targeting the marijuana industry for misconduct. Recently, the agency launched proceedings against CannAwake Corp. (OTC: CANX) for failing to file financial reports since December 2018, the year the company reported a net loss of $1,109,506...
-
Guernsey Issues Its First-Ever Medical Marijuana License: What It Means For This British Crown Territory
Wednesday, February 2, 2022 - 1:43pm | 451The Bailiwick of Guernsey Cannabis Agency has issued its first license in relation to CBD production. A bailiwick, by the way, is the area of jurisdiction of a bailiff. And Guernsey's BGCA just awarded the license to Celebrated, a company that makes a range of...
-
These 2 Cannabis Stocks Were Among The Most Searched Benzinga Tickers In 2021: Here's Why
Wednesday, January 5, 2022 - 12:49pm | 779Among the 20 most searched tickers on Benzinga in 2021 were two well-known cannabis companies. Here are their names and why they were heavily searched in 2021. Tilray: Ranking as the 18th most searched ticker on Benzinga Pro in 2021 was Tilray Inc (NASDAQ: TLRY). Operating in Canada and over 20...
-
NJ Sen. Menendez Presents Cannabis Insurance Bill To Enable 'Burgeoning Industry To Thrive'
Thursday, March 18, 2021 - 1:33pm | 438New Jersey Senator Bob Menendez confirmed Thursday the introduction of a bipartisan marijuana insurance bill. This new piece of legislature — The Clarifying Law Around Insurance of Marijuana (CLAIM) Act of 2021 — proposes enabling insurance coverage for cannabis and related...
-
Cannabis Stock Gainers And Losers From October 30, 2020
Friday, October 30, 2020 - 5:10pm | 836GAINERS: Golden Leaf Holdings (OTCQB: GLDFF) shares closed up 14.71% at $0.02 MedMen Enterprises (OTCQX: MMNFF) shares closed up 7.51% at $0.12 Delta 9 Cannabis (OTCQX: VRNDF) shares closed up 6.56% at $0.45 AusCann Group Holdings (OTCQX: ACNNF) shares closed up 5.26% at $0.10...
-
Aurora Cannabis Analyst Drops Bearish Stance, But Is Far From Convinced
Friday, February 14, 2020 - 4:37pm | 359Aurora Cannabis Inc. (TSE: ACB) (NYSE: ACB) still isn't a Buy, according to MKM Partners, but the sell-side firm dropped its bear stance on the stock Friday — still saying "issues abound" with the Canadian marijuana company's outlook. The Aurora Cannabis Analyst Bill...
-
GW Pharmaceuticals Takeover Talk 'Seems A Bit Premature'
Thursday, September 8, 2016 - 9:23am | 317Shares of GW Pharmaceuticals PLC - ADR (NASDAQ: GWPH) soared Wednesday from around $83 per share to close at $104.03 after Reuters reported the company is in talks with an investment banks to consider strategic alternatives. GW Pharmaceuticals is a developer of marijuana-based epilepsy...